PAX2 and endometrioid adenocarcinoma: Alterations in the immunohistochemical characteristics of ER, PTEN, PAX8, and PAX2 were noted in PDXs and their passages regardless of the parental tumor phenotypes, i.e., endometrioid carcinomas and carcinosarcomas.